1. A combination of Bristol-Myers Squibb Co. cancer drugs and radiation therapy can significantly improve survival rates in lung cancer patients, a new study shows. 2. A study found twice as many lung cancer patients were alive two and five years after diagnosis if they quit smoking before treatment. 3. Especially if you got a glimpse of the lung cancer patients. 4. In other lung cancer news, vitamin A may prevent lung cancer in former smokers, and the experimental drug Iressa shrinks tumors in advanced lung cancer patients. 5. Lung cancer patients now receive treatments based in part on the conclusions drawn from that trial. 6. Several early-stage studies of the drugs in lung cancer patients will be presented at the ASCO conference tomorrow. 7. Survival rates for lung cancer patients have been dismal because the disease typically is detected after it has begun to spread. 8. Such an effect is difficult to measure precisely, because of the high death and complication rate in very sick lung cancer patients, the company said. 9. The halt was called because some lung cancer patients who got the drug actually died sooner than those who took an inactive placebo. 10. The FTC also challenged claims that a procedure called bracytheraphy could improve the odds of survival among lung cancer patients. |